Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume 69, Issue 2, Pages 387-397
Publisher
Wiley
Online
2016-09-03
DOI
10.1002/art.39849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
- (2015) S. Y. Tian et al. JOURNAL OF RHEUMATOLOGY
- Active-comparator design and new-user design in observational studies
- (2015) Kazuki Yoshida et al. Nature Reviews Rheumatology
- Racial/Ethnic Variation in All-Cause Mortality Among United States Medicaid Recipients With Systemic Lupus Erythematosus: A Hispanic and Asian Paradox
- (2015) José A. Gómez-Puerta et al. Arthritis & Rheumatology
- Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus Nephritis
- (2015) Candace H. Feldman et al. Arthritis & Rheumatology
- Immunosuppressive Therapies for the Induction Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
- (2014) S. Y. Tian et al. JOURNAL OF RHEUMATOLOGY
- A Weighting Analogue to Pair Matching in Propensity Score Analysis
- (2013) Liang Li et al.
- Maintenance therapy of lupus nephritis with mycophenolate or azathioprine: systematic review and meta-analysis
- (2013) Jose R. Maneiro et al. RHEUMATOLOGY
- All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre
- (2013) J. Lee et al. RHEUMATOLOGY
- Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials
- (2012) Lorna K. Henderson et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004
- (2012) Candace H. Feldman et al. ARTHRITIS AND RHEUMATISM
- Systemic lupus erythematosus and infections: Clinical importance of conventional and upcoming biomarkers
- (2012) S. Sciascia et al. AUTOIMMUNITY REVIEWS
- Mycophenolate mofetilversusazathioprine as maintenance therapy for lupus nephritis: A meta-analysis
- (2012) Li Feng et al. NEPHROLOGY
- Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?
- (2012) Sengwee Toh et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents
- (2011) J. R. Curtis et al. ANNALS OF THE RHEUMATIC DISEASES
- Initiation of Tumor Necrosis Factor-α Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases
- (2011) Carlos G. Grijalva et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Indicators of Hospitalized Patients with Systemic Lupus Erythematosus: A Large Retrospective Multicenter Study in China
- (2011) X. FENG et al. JOURNAL OF RHEUMATOLOGY
- TNF-α Antagonist Use and Risk of Hospitalization for Infection in a National Cohort of Veterans With Rheumatoid Arthritis
- (2011) Michael A. Lane et al. MEDICINE
- Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis
- (2011) Mary Anne Dooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
- (2010) F. A. Houssiau et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis
- (2010) Z. TOUMA et al. JOURNAL OF RHEUMATOLOGY
- Access to Care and the Incidence of Endstage Renal Disease Due to Systemic Lupus Erythematosus
- (2010) M. M. WARD JOURNAL OF RHEUMATOLOGY
- Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis
- (2010) YH Lee et al. LUPUS
- Efficacy and Adverse Events of Mycophenolate Mofetil Versus Cyclophosphamide for Induction Therapy of Lupus Nephritis
- (2010) Nanticha Kamanamool et al. MEDICINE
- Some Methods of Propensity-Score Matching had Superior Performance to Others: Results of an Empirical Investigation and Monte Carlo simulations
- (2009) Peter C. Austin BIOMETRICAL JOURNAL
- Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
- (2009) Anja Strangfeld JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression
- (2009) A. Mak et al. RHEUMATOLOGY
- The risk of infection associated with tumor necrosis factor α antagonists: Making sense of epidemiologic evidence
- (2008) Daniel H. Solomon et al. ARTHRITIS AND RHEUMATISM
- Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients
- (2008) Nivedita M. Patkar et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started